Sermorelin Where to Buy: The Checks a Pharmacy Does First

Every sermorelin where to buy page you will find is a list of shops. That format fails for a simple reason: shops change hands, rebrand and change suppliers faster than a page gets updated, so a list is stale before it ranks. A set of checks does not go stale, because it describes what a document has to contain rather than who is currently selling.

There is a second reason to run checks rather than trust a name here. Sermorelin is not sold through one market. A compounding pharmacy can prepare it against a prescription, because sermorelin acetate was a component of an approved drug product and section 503A allows a compounder to work with exactly that. A research supplier sells the same molecule with a very different set of assurances attached. The checks below let you compare the two honestly.

We link one supplier and take a commission if you buy through it, which is set out on our affiliate disclosure page. That is precisely why this page scores the vendor we link against the same criteria as everyone else, and records where it comes up short.

The first check is whether a certificate exists and whether it names a batch. A purity figure printed on a product page with no document behind it is marketing copy. A document with no lot number cannot be matched to anything you receive. Both are common, and both are disqualifying.

The listing we link publishes a certificate for lot 38-01260229, analysed by MZ Biolabs in Tucson, Arizona on 7 February 2026 and signed on the thirteenth. That is a real document with a real laboratory, a named analyst and a date. It also means the scope of testing you are reading applies to that batch only, which is the discipline to keep in mind every time a vendor links one certificate under one product.

The practical version of this check happens after delivery, not before. Read the lot number stamped on the vial, then open the certificate the seller published and see whether the two agree. If they do not, you have a document about a batch you did not receive, which is worth roughly nothing.

A purity result tells you how much of the material in the vial is the main peak. It does not tell you that the main peak is the compound you ordered. Those are two different questions, and cheap operations answer only the first.

For this compound the identity target is specific enough to check yourself. Sermorelin is GHRH(1-29) amide, twenty-nine residues, sequence YADAIFTNSYRKVLGQLSARKLLQDIMSR with a C-terminal amide, formula C149H246N44O42S, molecular weight 3357.9 g/mol. Those values sit on PubChem CID 16132413. We converted the sequence printed on this certificate and it resolves to exactly that. The right molecule is described.

Mass spectrometry is what makes identity checkable, so look for it in the method line. This certificate reads HPLC-UV-MS with four detected peaks, which means a mass detector was in the path rather than ultraviolet absorbance alone. A certificate that reports purity by HPLC-UV only has measured how much of something is there without confirming what it is.

Here is where the vendor we link loses points. This lot's certificate reports purity and quantity. It carries no endotoxin test and no sterility test. For a lyophilised powder that gets reconstituted, those two assays cover the failure modes a purity number cannot reach, and they were not run on this batch.

That is not a hypothetical concern invented to fill a checklist. FDA's stated reason for placing several peptides in Category 2 of its bulk substances list is the risk for immunogenicity, which the agency ties to the potential for aggregation and peptide-related impurities. You can read the compounding framework on FDA's human drug compounding pages. A 99.79% purity result addresses part of that. Endotoxin and sterility address the rest, and they are missing here.

State this as a property of the batch. Lot 38-01260229 carries a certificate covering purity and quantity. Another lot may carry more. The check is not whether a vendor is good; it is whether the document attached to your batch lists the assays you care about.

Two checks are commercial rather than analytical. Domestic stock matters because a parcel that clears customs is a parcel that arrived, and because a long transit in a warm month is a variable nobody measured. A written refund policy matters because it is the only formal recourse in the transaction apart from your card issuer.

The quantity that reaches your card is $36.00 on a single vial once the code takes hold, from a $99.99 list and a $72.00 site price. Free shipping starts at $250, so a single vial usually carries postage, and postage belongs in your per-milligram figure. Quantity tiers of three, five and ten per cent come off the list price separately from the code, and whether they combine is not documented, so read the cart total rather than trusting an assumption.

Recourse is the check most readers skip and the one that matters if something goes wrong. On the research side, the parties who answer are the vendor under its own written policy and your bank. There is no adverse event reporting route, no pharmacist and no regulator holding a file on your purchase. That is the trade, and the honest thing is to name it rather than bury it.

Run all six and the picture is mixed rather than glowing, which is the useful kind of result. Batch-specific certificate: yes. Purity by a method with mass detection: yes, 99.79% by HPLC-UV-MS. Identity against the expected sequence and mass: yes, and we verified it independently. Quantity: 11.31 mg measured against a 10 mg label, which is 13.1% over on this lot and moves the effective cost from $3.60 to $3.18 per milligram.

Endotoxin: not on this certificate. Sterility: not on this certificate. Two of six unanswered, and they are the two that speak to what happens after the powder is dissolved. A page that linked this vendor and reported six from six would be lying to you, and our scoring method for sources weights those two heavily for exactly that reason.

The comparison that puts those two gaps in perspective is the prescription route, not another vendor. A compounding pharmacy operating under 503A works to standards that cover sterility for injectable preparations as a condition of practice rather than as an optional certificate line. That is most of what the extra cost and the extra weeks buy.

FDA's Category 2 bulk substances list names ibutamoren mesylate under both 503A and 503B, and it names ipamorelin acetate, GHRP-2, GHRP-6 and kisspeptin-10. Compounds such as BPC-157, MOTS-c and epitalon were nominated and then withdrawn. Sermorelin appears in none of those sections, and it never needed to, because it was a component of an approved drug product.

That single fact is why a where to buy page for this compound has a column that a page about most research peptides does not. Geref, approved in 1997 and now discontinued with FDA recording that the discontinuation was not for safety or effectiveness reasons, is the reason a compounding pharmacy can fill a sermorelin prescription today. If you want that route, our guide to how to get a sermorelin prescription sets out what a prescriber asks for and what it costs in time.

If you land on the research side anyway, do it with the checklist in hand rather than on the strength of a homepage. Match the lot, read the assay list, confirm the sequence and the mass, and treat the missing endotoxin and sterility lines as information rather than as a detail somebody forgot.